Long COVID : Does SARS‐CoV ‐2 induce lingering brain lesions?
European Journal of Neurology · 2023
DOI: 10.1111/ene.15751 ↗Kurz gefasst
Editorial in der Zeitschrift European Journal of Neurology, 2023. Verfasst von Jacques Hugon. Beteiligte Einrichtung: Cognitive Neurology Center, University of Paris City Lariboisière Hospital APHP, Paris, France. Hauptthemen laut MEDLINE: COVID-19, Nervous System Diseases. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 10 Literaturangaben.
Abstract (Originalsprache)
Hundreds of millions of COVID cases have been reported so far and long‐term lingering clinical symptoms are frequent and are called long COVID. Neurological signs including cognitive complaints are often described in long Covid. In COVID patients, the Sars‐Cov‐2 virus can reach the brain and could be responsible for cerebral anomalies observed in long COVID. Long‐term careful clinical follow‐up of these patients is necessary to detect early signs of neurodegeneration.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Cognitive Neurology Center, University of Paris City Lariboisière Hospital APHP, Paris, France.
Zitieren
APA
Hugon, J. (2023). Long COVID : Does SARS‐CoV ‐2 induce lingering brain lesions?. European Journal of Neurology. https://doi.org/10.1111/ene.15751
Vancouver
Hugon J. Long COVID : Does SARS‐CoV ‐2 induce lingering brain lesions?. European Journal of Neurology. 2023. doi:10.1111/ene.15751
BibTeX
@article{Hugon2023,
author = {Hugon, Jacques},
title = {Long COVID : Does SARS‐CoV ‐2 induce lingering brain lesions?},
journal = {European Journal of Neurology},
year = {2023},
doi = {10.1111/ene.15751}
}
EUVIMED